A 2025 ICMR-Lancet study reveals deep-seated challenges in India's newborn sickle cell screening, crucial for the National Sickle Cell Anaemia Elimination Mission targeting 2047. Social stigma, poor infrastructure, and lack of trained personnel in tribal regions are hampering early diagnosis and life-saving treatment, impacting a disease where India carries 16% of the global burden.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Global Burden (India): 16% of global Sickle Cell Disease cases
- ›National Screening Figures: 7.57 crore people screened, 2.66 lakh SCD cases, 21.66 lakh carriers identified
- ›Target this Data: India accounts for 16% of global Sickle Cell Disease burden.
- ›Target this Nodal Body: Indian Council of Medical Research (ICMR) - National Institute for Research on Blood and Immune Disorders (NIRBID), Mumbai.
- ›Target this Legal Point: National Sickle Cell Anaemia Elimination Mission with a target year of 2047.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.